Literature DB >> 17053071

Proinsulin is encoded by an RNA splice variant in human blood myeloid cells.

Parth Narendran1, Alana M Neale, Bo Han Lee, Katrina Ngui, Raymond J Steptoe, Grant Morahan, Ole Madsen, James A Dromey, Kent P Jensen, Leonard C Harrison.   

Abstract

Genes for peripheral tissue-restricted self-antigens are expressed in thymic and hematopoietic cells. In thymic medullary epithelial cells, self-antigen expression imposes selection on developing autoreactive T cells and regulates susceptibility to autoimmune disease in mouse models. Less is known about the role of self-antigen expression by hematopoietic cells. Here we demonstrate that one of the endocrine self-antigens expressed by human blood myeloid cells, proinsulin, is encoded by an RNA splice variant. The surface expression of immunoreactive proinsulin was significantly decreased after transfection of monocytes with small interfering RNA to proinsulin. Furthermore, analogous to proinsulin transcripts in the thymus, the abundance of the proinsulin RNA splice variant in blood cells corresponded with the length of the variable number of tandem repeats 5' of the proinsulin gene, known to be associated with type 1 diabetes susceptibility. Self-antigen expression by peripheral myeloid cells extends the umbrella of "immunological self" and, by analogy with the thymus, may be implicated in peripheral immune tolerance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053071      PMCID: PMC1618309          DOI: 10.1073/pnas.0607380103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The enemy within: keeping self-reactive T cells at bay in the periphery.

Authors:  Lucy S K Walker; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.

Authors:  J Derbinski; A Schulte; B Kyewski; L Klein
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

3.  High affinity binding sites for proinsulin in human IM-9 lymphoblasts.

Authors:  P M Jehle; M P Lutz; R D Fussgaenger
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells.

Authors:  L Klein; M Klugmann; K A Nave; V K Tuohy; B Kyewski
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

5.  Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes.

Authors:  W Chen; I Bergerot; J F Elliott; L C Harrison; N Abiru; G S Eisenbarth; T L Delovitch
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

6.  Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes.

Authors:  Aziz Alami Chentoufi; Constantin Polychronakos
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

7.  Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen.

Authors:  J Diez; Y Park; M Zeller; D Brown; D Garza; C Ricordi; J Hutton; G S Eisenbarth; A Pugliese
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

8.  A proinsulin gene splice variant with increased translation efficiency is expressed in human pancreatic islets.

Authors:  Anath Shalev; Patrick J Blair; Steven C Hoffmann; Boaz Hirshberg; Brenda A Peculis; David M Harlan
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

9.  Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes.

Authors:  G Rudy; N Stone; L C Harrison; P G Colman; P McNair; V Brusic; M B French; M C Honeyman; B Tait; A M Lew
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

10.  Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus.

Authors:  S T Bennett; A M Lucassen; S C Gough; E E Powell; D E Undlien; L E Pritchard; M E Merriman; Y Kawaguchi; M J Dronsfield; F Pociot
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

View more
  6 in total

Review 1.  Emerging roles of hematopoietic cells in the pathobiology of diabetic complications.

Authors:  Hideto Kojima; Jongoh Kim; Lawrence Chan
Journal:  Trends Endocrinol Metab       Date:  2014-02-04       Impact factor: 12.015

Review 2.  Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.

Authors:  Rebecca Fuhlbrigge; Linda Yip
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 3.  Antigen-based vaccination and prevention of type 1 diabetes.

Authors:  Leonard C Harrison; John M Wentworth; Yuxia Zhang; Esther Bandala-Sanchez; Ralph M Böhmer; Alana M Neale; Natalie L Stone; Gaetano Naselli; Julian J Bosco; Priscilla Auyeung; Maryam Rashidi; Petra Augstein; Grant Morahan
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 4.  Expression and function of the autoimmune regulator (Aire) gene in non-thymic tissue.

Authors:  S A Eldershaw; D M Sansom; P Narendran
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

5.  Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.

Authors:  E H Liu; B J Digon; B Hirshberg; R Chang; B J Wood; Z Neeman; A Kam; R A Wesley; S M Polly; R M Hofmann; K I Rother; D M Harlan
Journal:  Diabetologia       Date:  2009-05-06       Impact factor: 10.122

Review 6.  The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes.

Authors:  Leonard C Harrison
Journal:  Mol Metab       Date:  2021-07-07       Impact factor: 7.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.